AMANDA ESTRADA-SEARLS: Open Payments
NPI 1649746918 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 75 payments from 21 companies in 2025. Trend: 2023 $765 · 2024 $714 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $176 |
| Alkermes, Inc. | 5 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $135 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| Novo Nordisk Inc | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Abbott Laboratories | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| PFIZER INC. | 3 | $48 |
Products named: REXULTI, CAPLYTA, ARISTADA, COBENFY, INGREZZA, FREESTYLE LIBRE 3, SPRAVATO, Wegovy.
Industry payments across MI — which companies pay providers there.
